95 related articles for article (PubMed ID: 15288964)
1. Development of an efficient fluorescence-based microneutralization assay using recombinant human cytomegalovirus strains expressing green fluorescent protein.
Wang Z; Mo C; Kemble G; Duke G
J Virol Methods; 2004 Sep; 120(2):207-15. PubMed ID: 15288964
[TBL] [Abstract][Full Text] [Related]
2. A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.
Heineman TC; Schleiss M; Bernstein DI; Spaete RR; Yan L; Duke G; Prichard M; Wang Z; Yan Q; Sharp MA; Klein N; Arvin AM; Kemble G
J Infect Dis; 2006 May; 193(10):1350-60. PubMed ID: 16619181
[TBL] [Abstract][Full Text] [Related]
3. New cell-based indicator assays for the detection of human cytomegalovirus infection and screening of inhibitors of viral immediate-early 2 protein activity.
Luganini A; Caposio P; Mondini M; Landolfo S; Gribaudo G
J Appl Microbiol; 2008 Dec; 105(6):1791-801. PubMed ID: 19120629
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence-based antiviral assay for the evaluation of compounds against vaccinia virus, varicella zoster virus and human cytomegalovirus.
Dal Pozzo F; Andrei G; Daelemans D; Winkler M; Piette J; De Clercq E; Snoeck R
J Virol Methods; 2008 Jul; 151(1):66-73. PubMed ID: 18490063
[TBL] [Abstract][Full Text] [Related]
5. Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expression.
Biacchesi S; Skiadopoulos MH; Yang L; Murphy BR; Collins PL; Buchholz UJ
J Virol Methods; 2005 Sep; 128(1-2):192-7. PubMed ID: 15955576
[TBL] [Abstract][Full Text] [Related]
6. An improved plaque reduction virus neutralization assay for human metapneumovirus.
de Graaf M; Herfst S; Schrauwen EJ; van den Hoogen BG; Osterhaus AD; Fouchier RA
J Virol Methods; 2007 Aug; 143(2):169-74. PubMed ID: 17420056
[TBL] [Abstract][Full Text] [Related]
7. Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis.
Zielinska E; Liu D; Wu HY; Quiroz J; Rappaport R; Yang DP
Virol J; 2005 Nov; 2():84. PubMed ID: 16281972
[TBL] [Abstract][Full Text] [Related]
8. Development of a high-throughput Alamar blue assay for the determination of influenza virus infectious dose, serum antivirus neutralization titer and virus ca/ts phenotype.
Mo C; Yamagata R; Pan A; Reddy J; Hazari N; Duke G
J Virol Methods; 2008 Jun; 150(1-2):63-9. PubMed ID: 18423899
[TBL] [Abstract][Full Text] [Related]
9. Plaque-reduction assays for human and simian immunodeficiency virus neutralization.
Nordqvist A; Fenyö EM
Methods Mol Biol; 2005; 304():273-85. PubMed ID: 16061983
[TBL] [Abstract][Full Text] [Related]
10. Novel real-time monitoring system for human cytomegalovirus-infected cells in vitro that uses a green fluorescent protein-PML-expressing cell line.
Ueno T; Eizuru Y; Katano H; Kurata T; Sata T; Irie S; Ogawa-Goto K
Antimicrob Agents Chemother; 2006 Aug; 50(8):2806-13. PubMed ID: 16870775
[TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of a recombinant ovine lentivirus carrying the optimized green fluorescent protein gene at the dUTPase locus.
Zhang Z; Guo J; Ni Y; Bazer FW; Giavedoni L; de la Concha-Bermejillo A
Arch Virol; 2003 Aug; 148(8):1485-506. PubMed ID: 12898327
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a recombinant encephalomyocarditis virus expressing the enhanced green fluorescent protein.
Hammoumi S; Cruciere C; Guy M; Boutrouille A; Messiaen S; Lecollinet S; Bakkali-Kassimi L
Arch Virol; 2006 Sep; 151(9):1783-96. PubMed ID: 16575480
[TBL] [Abstract][Full Text] [Related]
13. Expression and recombination of the EGFP and EYFP genes in lentiviral vectors carrying two heterologous promoters.
Dijon M; Torne-Celer C; Moreau T; Tonnelle C; Chabannon C
Cytotherapy; 2005; 7(5):417-26. PubMed ID: 16236631
[TBL] [Abstract][Full Text] [Related]
14. [Construction and growth properties of recombinant pseudorabies virus expressing modified enhanced green fluorescent protein].
Fang LR; Chen HC; Xiao SB; Zhang H; Niu CS
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Nov; 34(6):757-62. PubMed ID: 12417920
[TBL] [Abstract][Full Text] [Related]
15. An indicator cell assay for detection of human cytomegalovirus based on enhanced green fluorescent protein.
Liu WT; Sun JR; Lin CH; Kuo RL; Kung SH
J Virol Methods; 2001 Jul; 96(1):85-92. PubMed ID: 11516491
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide sequence comparisons between several strains and isolates of human cytomegalovirus reveal alternate start codon usage.
Brondke H; Schmitz B; Doerfler W
Arch Virol; 2007; 152(11):2035-46. PubMed ID: 17653620
[TBL] [Abstract][Full Text] [Related]
17. Effect of serum and CTL on focal growth of human cytomegalovirus.
Sinzger C; Mangin M; Weinstock C; Topp MS; Hebart H; Einsele H; Jahn G
J Clin Virol; 2007 Feb; 38(2):112-9. PubMed ID: 17204454
[TBL] [Abstract][Full Text] [Related]
18. A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques.
Chang WL; Tarantal AF; Zhou SS; Borowsky AD; Barry PA
J Virol; 2002 Sep; 76(18):9493-504. PubMed ID: 12186931
[TBL] [Abstract][Full Text] [Related]
19. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation.
Pumannova M; Roubalova K; Vitek A; Sajdova J
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):115-20. PubMed ID: 16406183
[TBL] [Abstract][Full Text] [Related]
20. Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and Toledo.
Suárez NM; Lau B; Kemble GM; Lee R; Mocarski ES; Wilkinson GWG; Adler SP; McVoy MA; Davison AJ
Virus Genes; 2017 Aug; 53(4):650-655. PubMed ID: 28391502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
